Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Centella asiatica plus silver sulfadiazine versus silver sulfadiazine alone for second-degree burns
IRCT20260217068898N2Phase 3Recruiting
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of silver sulfadiazine in burn injury, partial-thickness burn, sponsored by Isfahan University of Medical Sciences. Started Oct 2026; status: recruiting.
02
Drugs
silver sulfadiazine
03
Conditions
burn injurypartial-thickness burn
Beyond the preview
Go deeper on IRCT20260217068898N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260217068898N2.